Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Ibrutinib does not affect ristocetin-induced platelet aggregation evaluated by light transmission aggregometry in chronic lymphocytic leukemia patients.

Alberelli MA, Innocenti I, Autore F, Laurenti L, De Candia E.

Haematologica. 2018 Mar;103(3):e119-e122. doi: 10.3324/haematol.2017.179044. Epub 2017 Dec 14. No abstract available.

2.

Bleeding risk of surgery and its prevention in patients with inherited platelet disorders.

Orsini S, Noris P, Bury L, Heller PG, Santoro C, Kadir RA, Butta NC, Falcinelli E, Cid AR, Fabris F, Fouassier M, Miyazaki K, Lozano ML, Zúñiga P, Flaujac C, Podda GM, Bermejo N, Favier R, Henskens Y, De Maistre E, De Candia E, Mumford AD, Ozdemir GN, Eker I, Nurden P, Bayart S, Lambert MP, Bussel J, Zieger B, Tosetto A, Melazzini F, Glembotsky AC, Pecci A, Cattaneo M, Schlegel N, Gresele P; European Hematology Association - Scientific Working Group (EHA-SWG) on thrombocytopenias and platelet function disorders.

Haematologica. 2017 Jul;102(7):1192-1203. doi: 10.3324/haematol.2016.160754. Epub 2017 Apr 6.

3.

Portal vein thrombosis occurrence in a cirrhotic patient during treatment with rivaroxaban.

Ponziani FR, De Candia E, De Cristofaro R, Pompili M.

Liver Int. 2017 Aug;37(8):1251. doi: 10.1111/liv.13406. Epub 2017 Mar 30. No abstract available.

PMID:
28267885
4.

NETosis in arterial and venous thrombosis: a one size fits all mechanism?

De Candia E.

Intern Emerg Med. 2017 Feb;12(1):9-11. doi: 10.1007/s11739-016-1600-x. Epub 2017 Jan 9. No abstract available.

PMID:
28066864
5.

PO-54 - Clinical and laboratory characterization of platelet dysfunction caused by ibrutinib treatment in patients with chronic lymphocytic leukemia.

Alberelli MA, Innocenti I, Sica S, Laurenti L, De Candia E.

Thromb Res. 2016 Apr;140 Suppl 1:S196. doi: 10.1016/S0049-3848(16)30187-6. Epub 2016 Apr 8.

PMID:
27161742
6.

Corrigendum: Abnormal proplatelet formation and emperipolesis in cultured human megakaryocytes from gray platelet syndrome patients.

Di Buduo CA, Alberelli MA, Glembotsky AC, Podda G, Lev PR, Cattaneo M, Landolfi R, Heller PG, Balduini A, De Candia E.

Sci Rep. 2016 Apr 29;6:25027. doi: 10.1038/srep25027. No abstract available.

7.

Abnormal proplatelet formation and emperipolesis in cultured human megakaryocytes from gray platelet syndrome patients.

Di Buduo CA, Alberelli MA, Glembostky AC, Podda G, Lev PR, Cattaneo M, Landolfi R, Heller PG, Balduini A, De Candia E.

Sci Rep. 2016 Mar 18;6:23213. doi: 10.1038/srep23213. Erratum in: Sci Rep. 2016 Apr 29;6:25027.

8.

Impact of Gut Microbiota on Obesity, Diabetes, and Cardiovascular Disease Risk.

Miele L, Giorgio V, Alberelli MA, De Candia E, Gasbarrini A, Grieco A.

Curr Cardiol Rep. 2015 Dec;17(12):120. doi: 10.1007/s11886-015-0671-z. Review.

PMID:
26497040
9.

Megakaryocytic emperipolesis and platelet function abnormalities in five patients with gray platelet syndrome.

Larocca LM, Heller PG, Podda G, Pujol-Moix N, Glembotsky AC, Pecci A, Alberelli MA, Balduini CL, Landolfi R, Cattaneo M, De Candia E.

Platelets. 2015;26(8):751-7. doi: 10.3109/09537104.2014.994093. Epub 2015 Mar 25.

PMID:
25806575
10.

Platelet diameters in inherited thrombocytopenias: analysis of 376 patients with all known disorders.

Noris P, Biino G, Pecci A, Civaschi E, Savoia A, Seri M, Melazzini F, Loffredo G, Russo G, Bozzi V, Notarangelo LD, Gresele P, Heller PG, Pujol-Moix N, Kunishima S, Cattaneo M, Bussel J, De Candia E, Cagioni C, Ramenghi U, Barozzi S, Fabris F, Balduini CL.

Blood. 2014 Aug 7;124(6):e4-e10. doi: 10.1182/blood-2014-03-564328. Epub 2014 Jul 2.

11.

Functional role of protease activated receptors in vascular biology.

Alberelli MA, De Candia E.

Vascul Pharmacol. 2014 Aug;62(2):72-81. doi: 10.1016/j.vph.2014.06.001. Epub 2014 Jun 9. Review.

PMID:
24924409
12.

Analysis of 339 pregnancies in 181 women with 13 different forms of inherited thrombocytopenia.

Noris P, Schlegel N, Klersy C, Heller PG, Civaschi E, Pujol-Moix N, Fabris F, Favier R, Gresele P, Latger-Cannard V, Cuker A, Nurden P, Greinacher A, Cattaneo M, De Candia E, Pecci A, Hurtaud-Roux MF, Glembotsky AC, Muñiz-Diaz E, Randi ML, Trillot N, Bury L, Lecompte T, Marconi C, Savoia A, Balduini CL, Bayart S, Bauters A, Benabdallah-Guedira S, Boehlen F, Borg JY, Bottega R, Bussel J, De Rocco D, de Maistre E, Faleschini M, Falcinelli E, Ferrari S, Ferster A, Fierro T, Fleury D, Fontana P, James C, Lanza F, Le Cam Duchez V, Loffredo G, Magini P, Martin-Coignard D, Menard F, Mercier S, Mezzasoma A, Minuz P, Nichele I, Notarangelo LD, Pippucci T, Podda GM, Pouymayou C, Rigouzzo A, Royer B, Sie P, Siguret V, Trichet C, Tucci A, Saposnik B, Veneri D; European Hematology Association – Scientific Working Group on Thrombocytopenias and Platelet Function Disorders.

Haematologica. 2014 Aug;99(8):1387-94. doi: 10.3324/haematol.2014.105924. Epub 2014 Apr 24.

13.

MYH9-related disease: a novel prognostic model to predict the clinical evolution of the disease based on genotype-phenotype correlations.

Pecci A, Klersy C, Gresele P, Lee KJ, De Rocco D, Bozzi V, Russo G, Heller PG, Loffredo G, Ballmaier M, Fabris F, Beggiato E, Kahr WH, Pujol-Moix N, Platokouki H, Van Geet C, Noris P, Yerram P, Hermans C, Gerber B, Economou M, De Groot M, Zieger B, De Candia E, Fraticelli V, Kersseboom R, Piccoli GB, Zimmermann S, Fierro T, Glembotsky AC, Vianello F, Zaninetti C, Nicchia E, Güthner C, Baronci C, Seri M, Knight PJ, Balduini CL, Savoia A.

Hum Mutat. 2014 Feb;35(2):236-47. doi: 10.1002/humu.22476. Epub 2013 Dec 12.

14.

Correlation between platelet phenotype and NBEAL2 genotype in patients with congenital thrombocytopenia and α-granule deficiency.

Bottega R, Pecci A, De Candia E, Pujol-Moix N, Heller PG, Noris P, De Rocco D, Podda GM, Glembotsky AC, Cattaneo M, Balduini CL, Savoia A.

Haematologica. 2013 Jun;98(6):868-74. doi: 10.3324/haematol.2012.075861. Epub 2012 Oct 25.

15.

Mechanisms of platelet activation by thrombin: a short history.

De Candia E.

Thromb Res. 2012 Mar;129(3):250-6. doi: 10.1016/j.thromres.2011.11.001. Epub 2011 Dec 2. Review.

PMID:
22137742
16.

Prevalence and significance of anti-prothrombin (aPT) antibodies in patients with Lupus Anticoagulant (LA).

Pengo V, Denas G, Bison E, Banzato A, Jose SP, Gresele P, Marongiu F, Erba N, Veschi F, Ghirarduzzi A, De Candia E, Montaruli B, Marietta M, Testa S, Barcellona D, Tripodi A; Italian Federation of Thrombosis Centers (FCSA).

Thromb Res. 2010 Aug;126(2):150-3. doi: 10.1016/j.thromres.2010.05.018. Epub 2010 Jun 9.

PMID:
20542544
17.

Management of bleeding and of invasive procedures in patients with platelet disorders and/or thrombocytopenia: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET).

Tosetto A, Balduini CL, Cattaneo M, De Candia E, Mariani G, Molinari AC, Rossi E, Siragusa S; Italian Society for Haemostasis and Thrombosis.

Thromb Res. 2009 Nov;124(5):e13-8. doi: 10.1016/j.thromres.2009.06.009. Epub 2009 Jul 24.

PMID:
19631969
18.

Position of nonmuscle myosin heavy chain IIA (NMMHC-IIA) mutations predicts the natural history of MYH9-related disease.

Pecci A, Panza E, Pujol-Moix N, Klersy C, Di Bari F, Bozzi V, Gresele P, Lethagen S, Fabris F, Dufour C, Granata A, Doubek M, Pecoraro C, Koivisto PA, Heller PG, Iolascon A, Alvisi P, Schwabe D, De Candia E, Rocca B, Russo U, Ramenghi U, Noris P, Seri M, Balduini CL, Savoia A.

Hum Mutat. 2008 Mar;29(3):409-17.

PMID:
18059020
19.
20.

Survey of lupus anticoagulant diagnosis by central evaluation of positive plasma samples.

Pengo V, Biasiolo A, Gresele P, Marongiu F, Erba N, Veschi F, Ghirarduzzi A, de Candia E, Montaruli B, Testa S, Barcellona D, Tripodi A; Participating Centres of Italian Federation of Thrombosis Centres (FCSA).

J Thromb Haemost. 2007 May;5(5):925-30.

21.

Surgical bleeding after pre-operative unfractionated heparin and low molecular weight heparin for coronary bypass surgery.

Renda G, Di Pillo R, D'Alleva A, Sciartilli A, Zimarino M, De Candia E, Landolfi R, Di Giammarco G, Calafiore A, De Caterina R.

Haematologica. 2007 Mar;92(3):366-73.

22.

Defective platelet responsiveness to thrombin and protease-activated receptors agonists in a novel case of gray platelet syndrome: correlation between the platelet defect and the alpha-granule content in the patient and four relatives.

De Candia E, Pecci A, Ciabattoni G, De Cristofaro R, Rutella S, Yao-Wu Z, Lazzareschi I, Landolfi R, Coughlin S, Balduini CL.

J Thromb Haemost. 2007 Mar;5(3):551-9. Epub 2006 Nov 28.

23.

Abnormal pH-sensing of platelet Na+/H+ exchanger in patients with cardiac syndrome X.

De Candia E, Lanza GA, Romagnoli E, Ciabattoni G, Sestito A, Pasqualetti P, Crea F, Maseri A, Landolfi R.

Int J Cardiol. 2005 Apr 28;100(3):371-6.

PMID:
15837078
24.

Lipophilicity-related inhibition of blood platelet aggregation by nipecotic acid anilides.

De Marco A, De Candia M, Carotti A, Cellamare S, De Candia E, Altomare C.

Eur J Pharm Sci. 2004 Jun;22(2-3):153-64.

PMID:
15158900
25.

Thrombin domains: structure, function and interaction with platelet receptors.

De Cristofaro R, De Candia E.

J Thromb Thrombolysis. 2003 Jun;15(3):151-63. Review.

PMID:
14739624
26.

Increased platelet sodium-hydrogen exchanger activity in patients with variant angina.

Lanza GA, De Candia E, Romagnoli E, Messano L, Sestito A, Landolfi R, Crea F, Maseri A.

Heart. 2003 Aug;89(8):935-6. No abstract available.

27.

Combined role of the Lewis antigenic system, Chlamydia pneumoniae, and C-reactive protein in unstable angina.

Angiolillo DJ, Liuzzo G, Pelliccioni S, De Candia E, Landolfi R, Crea F, Maseri A, Biasucci LM.

J Am Coll Cardiol. 2003 Feb 19;41(4):546-50.

28.

Structural and functional mapping of the thrombin domain involved in the binding to the platelet glycoprotein Ib.

De Cristofaro R, De Candia E, Landolfi R, Rutella S, Hall SW.

Biochemistry. 2001 Nov 6;40(44):13268-73.

PMID:
11683636
29.

Binding of thrombin to glycoprotein Ib accelerates the hydrolysis of Par-1 on intact platelets.

De Candia E, Hall SW, Rutella S, Landolfi R, Andrews RK, De Cristofaro R.

J Biol Chem. 2001 Feb 16;276(7):4692-8. Epub 2000 Nov 17.

30.

Hepatocellular carcinoma complicating liver cirrhosis in type IIIa glycogen storage disease.

Siciliano M, De Candia E, Ballarin S, Vecchio FM, Servidei S, Annese R, Landolfi R, Rossi L.

J Clin Gastroenterol. 2000 Jul;31(1):80-2.

PMID:
10914784
32.

Thrombin-induced platelet activation is inhibited by high- and low-molecular-weight heparin.

De Candia E, De Cristofaro R, Landolfi R.

Circulation. 1999 Jun 29;99(25):3308-14.

PMID:
10385507
33.

Thrombin interaction with platelet GpIb: structural mapping and effects on platelet activation (review).

De Cristofaro R, De Candia E.

Int J Mol Med. 1999 Apr;3(4):363-71. Review.

PMID:
10085407
34.

Effect of high- and low-molecular-weight heparins on thrombin-thrombomodulin interaction and protein C activation.

De Cristofaro R, De Candia E, Landolfi R.

Circulation. 1998 Sep 29;98(13):1297-301.

PMID:
9751678
35.

Binding of human alpha-thrombin to platelet GpIb: energetics and functional effects.

de Cristofaro R, de Candia E, Croce G, Morosetti R, Landolfi R.

Biochem J. 1998 Jun 15;332 ( Pt 3):643-50.

36.

Thrombin interaction with platelet GpIB: role of the heparin binding domain.

De Candia E, De Cristofaro R, De Marco L, Mazzucato M, Picozzi M, Landolfi R.

Thromb Haemost. 1997 Apr;77(4):735-40.

PMID:
9134652
37.

Thrombin-thrombomodulin interaction: energetics and potential role of water as an allosteric effector.

De Cristofaro R, Picozzi M, De Candia E, Rocca B, Landolfi R.

Biochem J. 1995 Aug 15;310 ( Pt 1):49-53.

38.
39.

Effects of unfractionated and low molecular weight heparins on platelet thromboxane biosynthesis "in vivo".

Landolfi R, De Candia E, Rocca B, Ciabattoni G, Antinori A, Masetti R, Patrono C.

Thromb Haemost. 1994 Dec;72(6):942-6.

PMID:
7740468
40.

Lymph node blast crisis in chronic myeloid leukemia mimicking T-immunoblastic lymphoma.

Leone G, La Rocca LM, Teofili L, De Candia E, Landolfi R, Sica S, Zini G, Zollino M, Tabilio A.

Haematologica. 1992 Jul-Aug;77(4):311-4.

PMID:
1427440
41.

Effect of fibrinogen concentration on the velocity of platelet aggregation.

Landolfi R, De Cristofaro R, De Candia E, Rocca B, Bizzi B.

Blood. 1991 Jul 15;78(2):377-81.

42.

Inhibition of fibrinogen binding to human platelets by blockage of Na+/H+ exchange.

De Cristofaro R, Landolfi R, Di Cera E, Castagnola M, De Candia E, Bizzi B.

Biochem Biophys Res Commun. 1989 Jun 30;161(3):1228-32.

PMID:
2545197
43.

Effect of picotamide on prostacyclin production by human endothelial cells.

Landolfi R, Castellana MA, De Cristofaro R, De Candia E, Bizzi B.

Thromb Haemost. 1988 Dec 22;60(3):529. No abstract available.

PMID:
3070827
44.

Meningeal hematopoiesis causing exophthalmus and hemiparesis in myelofibrosis: effect of radiotherapy. A case report.

Landolfi R, Colosimo C Jr, De Candia E, Castellana MA, De Cristofaro R, Trodella L, Leone G.

Cancer. 1988 Dec 1;62(11):2346-9.

PMID:
3179950
45.

Allosteric equilibria in the binding of fibrinogen to platelets.

De Cristofaro R, Landolfi R, De Candia E, Castagnola M, Di Cera E, Wyman J.

Proc Natl Acad Sci U S A. 1988 Nov;85(22):8473-6.

46.

Increased platelet-fibrinogen affinity in patients with myeloproliferative disorders.

Landolfi R, De Cristofaro R, Castagnola M, De Candia E, D'Onofrio G, Leone G, Bizzi B.

Blood. 1988 Apr;71(4):978-82.

Supplemental Content

Loading ...
Support Center